Coronary artery multi-vessel disease and left main stenosis
Conditions
Brief summary
A composite endpoint of the time to all cause death, or myocardial infarction, or stroke, or new coronary revascularization within 12 months
Detailed description
Time to all cause death, Time to all cause death, myocardial infarction or stroke, Time to cardiovascular death, Time to first myocardial infarction, Time to first stroke, Time to new revascularization, Time to coronary angiography, Time to hospitalization for heart failure, Time to cardiovascular hospitalization, Time to sudden death or aborted cardiac arrest, Time to new-onset AF
Interventions
DRUGACETYLSALICYLIC ACID
DRUGTICAGRELOR
Sponsors
Vaestra Goetalandsregionen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A composite endpoint of the time to all cause death, or myocardial infarction, or stroke, or new coronary revascularization within 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to all cause death, Time to all cause death, myocardial infarction or stroke, Time to cardiovascular death, Time to first myocardial infarction, Time to first stroke, Time to new revascularization, Time to coronary angiography, Time to hospitalization for heart failure, Time to cardiovascular hospitalization, Time to sudden death or aborted cardiac arrest, Time to new-onset AF | — |
Countries
Denmark, Finland, Iceland, Norway, Sweden
Outcome results
None listed